Investor Relations

EnteroMedics Inc. was established in late 2002 to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus.

At its Saint Paul, Minnesota headquarters, EnteroMedics employs approximately 70 dedicated professionals with vast experience in basic and applied research, technology development, clinical evaluation, quality processes, regulatory submissions and business acumen.

 

 

Home | What is VBLOC^TM Therapy? | Why VBLOC^TM Therapy? | Bariatric Weight Loss Surgery
Surgical Candidates | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised November 2007.

©Copyright 2007 EnteroMedics. All rights reserved. Nothing in this site, including descriptions of treatments may be reproduced without written authorization from EnteroMedics.